Preclinical evaluation of 131 I-Bevacizumab – A prospective agent for radioimmunotherapy in VEGF expressing cancers

Mythili Kameswaran, Haladhar Dev Sarma, Ashutosh Dash
  • Applied Radiation and Isotopes, May 2017, Elsevier
  • DOI: 10.1016/j.apradiso.2017.02.024
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1016/j.apradiso.2017.02.024

The following have contributed to this page: Haladhar Dev Sarma